Cogent Biosciences (COGT) Interest Expenses (2017 - 2026)
Cogent Biosciences (COGT) posted quarterly Interest Expenses of $6.8 million for Q1 2026, up 170575.0% year-over-year from N/an in Q1 2025, and up 440.97% quarter-over-quarter from $1.3 million in Q4 2025.
Cogent Biosciences (COGT) Interest Expenses (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Interest Expenses for 10 consecutive years, with $6.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 170575.0% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (up 170575.0% YoY), while the FY2025 annual figure was $747.2 million, up 241.87% from the prior year.
- Interest Expenses climbed to $6.8 million in Q1 2026 per COGT's latest filing, from $1.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $39.0 million in Q2 2022 and bottomed at $4000.0 in Q1 2025.
- Historically, Interest Expenses has averaged $5.1 million across 5 years, with a median of $1.2 million in 2023.
- Annual changes were most pronounced in 2023 — Interest Expenses tumbled 99.73% — and 2026, when it jumped 170575.0%.
- Cogent Biosciences' Interest Expenses stood at $391000.0 in 2022, then surged by 202.81% to $1.2 million in 2023, then soared by 209.38% to $3.7 million in 2024, then slumped by 65.55% to $1.3 million in 2025, then surged by 440.97% to $6.8 million in 2026.
- Business Quant data shows COGT's Interest Expenses at $6.8 million in Q1 2026, $1.3 million in Q4 2025, and $5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | 6.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.54 Mn |
| Jun 30, 2026 | 6.54 Mn |
| Mar 31, 2026 | 6.83 Mn |
| Mar 31, 2026 | 6.83 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 5.75 Mn |
| Sep 30, 2025 | 5.75 Mn |
| Jun 30, 2025 | 314,000.00 |
| Jun 30, 2025 | 314,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 3.66 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Jun 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Dec 31, 2023 | 1.18 Mn |